24 related articles for article (PubMed ID: 38518034)
1. Comprehensive pan-cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance.
Chen Q; Gao F; Wu J; Zhang K; Du T; Chen Y; Cai R; Zhao D; Deng R; Tang J
Clin Transl Med; 2024 Jun; 14(6):e1735. PubMed ID: 38899748
[TBL] [Abstract][Full Text] [Related]
2. HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus-associated cancers.
Liu L; Xie Y; Yang H; Lin A; Dong M; Wang H; Zhang C; Liu Z; Cheng Q; Zhang J; Yuan S; Luo P
Imeta; 2023 Aug; 2(3):e130. PubMed ID: 38867938
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor.
Mo Z; Li P; Cao Z; Zhang S
Front Immunol; 2021; 12():564948. PubMed ID: 34290693
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
5. Proteomic Profiling Identifies PTK2/FAK as a Driver of Radioresistance in HPV-negative Head and Neck Cancer.
Skinner HD; Giri U; Yang L; Woo SH; Story MD; Pickering CR; Byers LA; Williams MD; El-Naggar A; Wang J; Diao L; Shen L; Fan YH; Molkentine DP; Beadle BM; Meyn RE; Myers JN; Heymach JV
Clin Cancer Res; 2016 Sep; 22(18):4643-50. PubMed ID: 27036135
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and immunotherapeutic significance of mannose receptor C type II in 33 cancers: An integrated analysis.
Zhao Z; Yang Y; Liu Z; Chen H; Guan X; Jiang Z; Yang M; Liu H; Chen T; Gao Y; Zou S; Wang X
Front Mol Biosci; 2022; 9():951636. PubMed ID: 36188226
[No Abstract] [Full Text] [Related]
8. Comprehensive pan-cancer analysis of 33 human cancers reveals immunotherapeutic value of focal adhesion tyrosine kinase.
Shi Y; Ju M; Zhang Y; Liang L; Sun X; Di X
Medicine (Baltimore); 2024 Mar; 103(12):e37362. PubMed ID: 38518034
[TBL] [Abstract][Full Text] [Related]
9. New insights into FAK structure and function in focal adhesions.
Le Coq J; Acebrón I; Rodrigo Martin B; López Navajas P; Lietha D
J Cell Sci; 2022 Oct; 135(20):. PubMed ID: 36239192
[TBL] [Abstract][Full Text] [Related]
10. A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2).
Jiang ZH; Shen X; Wei Y; Chen Y; Chai H; Xia L; Leng W
Front Genet; 2022; 13():927046. PubMed ID: 35937984
[No Abstract] [Full Text] [Related]
11. Emerging roles of focal adhesion kinase in cancer.
Tai YL; Chen LC; Shen TL
Biomed Res Int; 2015; 2015():690690. PubMed ID: 25918719
[TBL] [Abstract][Full Text] [Related]
12. FAK Structure and Regulation by Membrane Interactions and Force in Focal Adhesions.
Tapial Martínez P; López Navajas P; Lietha D
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31991559
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
